Bausch Health Companies 404280DR7 Bond

BHC Stock  USD 7.95  0.02  0.25%   
At present, Bausch Health's Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Short Term Debt is expected to grow to about 536.5 M, whereas Long Term Debt is forecasted to decline to about 14 B. With a high degree of financial leverage come high-interest payments, which usually reduce Bausch Health's Earnings Per Share (EPS).
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.81857404
Current Value
0.86
Quarterly Volatility
0.12262746
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, Bausch Health's Non Current Liabilities Total is projected to increase significantly based on the last few years of reporting.
  
Check out the analysis of Bausch Health Fundamentals Over Time.
View Bond Profile
Given the importance of Bausch Health's capital structure, the first step in the capital decision process is for the management of Bausch Health to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Bausch Health Companies to issue bonds at a reasonable cost.
Popular NameBausch Health HSBC Holdings PLC
SpecializationPharmaceuticals, Biotechnology & Life Sciences
Equity ISIN CodeCA0717341071
Bond Issue ISIN CodeUS404280DR76
S&P Rating
Others
Maturity Date3rd of November 2028
Issuance Date3rd of November 2022
Coupon7.39 %
View All Bausch Health Outstanding Bonds

Bausch Health Companies Outstanding Bond Obligations

Understaning Bausch Health Use of Financial Leverage

Bausch Health's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Bausch Health's total debt position, including all outstanding debt obligations, and compares it with Bausch Health's equity. Financial leverage can amplify the potential profits to Bausch Health's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Bausch Health is unable to cover its debt costs.
Last ReportedProjected for Next Year
Short and Long Term Debt Total22.4 B23.5 B
Net Debt21.4 B22.5 B
Short Term Debt511 M536.5 M
Long Term Debt21.9 B14 B
Long Term Debt Total23.4 B21.5 B
Short and Long Term Debt450 M465.3 M
Net Debt To EBITDA 7.43  6.70 
Debt To Equity(21.91)(20.81)
Interest Debt Per Share 64.99  68.24 
Debt To Assets 0.82  0.86 
Long Term Debt To Capitalization 1.05  1.10 
Total Debt To Capitalization 1.05  1.10 
Debt Equity Ratio(21.91)(20.81)
Debt Ratio 0.82  0.86 
Cash Flow To Debt Ratio 0.05  0.04 
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out the analysis of Bausch Health Fundamentals Over Time.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Earnings Share
(0.48)
Revenue Per Share
25.794
Quarterly Revenue Growth
0.122
Return On Assets
0.0415
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.